Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
暂无分享,去创建一个
M. Hellard | E. Miller | S. Bowden | M. Bharadwaj | M E Hellard | C K Aitken | M Bharadwaj | E R Miller | S Bowden | C. Aitken
[1] J. Hocking,et al. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities , 2004, Epidemiology and Infection.
[2] M. Hellard,et al. Change in hepatitis C virus genotype in injecting drug users , 2004, Journal of medical virology.
[3] Rohan Jayasuriya,et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. , 2006, Addiction.
[4] Campbell K Aitken,et al. Molecular epidemiology of hepatitis C virus in a social network of injection drug users. , 2004, The Journal of infectious diseases.
[5] J. Tran van Nhieu,et al. Characteristics of patients with dual infection by hepatitis B and C viruses. , 1998, Journal of hepatology.
[6] P. Bi,et al. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[7] P. Lopalco,et al. Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy , 2004, Journal of medical virology.
[8] P. Haber,et al. Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route , 2001, The Medical journal of Australia.
[9] J. March,et al. Drugs and Social Exclusion in Ten European Cities , 2005, European Addiction Research.
[10] J. Edeh,et al. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England. , 2000, Journal of public health medicine.
[11] A. Bradford. The Australian Immunisation Handbook , 2000 .
[12] J. Kaldor,et al. Estimates of chronic hepatitis B virus infection in Australia, 2000 , 2004, Australian and New Zealand journal of public health.
[13] M. Hellard,et al. The prevalence and risk behaviours associated with the transmission of blood‐borne viruses among ethnic‐Vietnamese injecting drug users , 2006, Australian and New Zealand journal of public health.
[14] B. Jalaludin,et al. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south‐western Sydney, Australia , 2004, Journal of gastroenterology and hepatology.
[15] Julia L Young,et al. Social Inclusion Research Unit Social and Community 1-12000 The War on Drugs – A War on Drug Users , 2013 .
[16] Edoardo Cervoni,et al. Hepatitis C , 1998, The Lancet.
[17] S Wacholder,et al. Binomial regression in GLIM: estimating risk ratios and risk differences. , 1986, American journal of epidemiology.
[18] J. Hou,et al. Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection , 2006, International journal of medical sciences.
[19] S. Gore,et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? , 2000, The Journal of infection.
[20] A. Barros,et al. BMC Medical Research Methodology , 2003 .